Cognition Therapeutics Publishes Clinical Evidence that
- First Human Evidence that CT1812 Selectively Engages Aβ Oligomers...
Source: globenewswire.com
Stay updated with breaking news from Disease Using. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- First Human Evidence that CT1812 Selectively Engages Aβ Oligomers...
The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated immunoassay analyzers, enabling patients to get broad...